Airlympus - Asthma

  • Study Sponsor and Protocol Number: 
    Sanofi ACT18301
  • Specialty:
    Pulmonology
  • Type:
    Investigational Drug
  • Inclusion:
    Age 18-80
    Mild to moderate asthma
    SMI 18.5-40
    2 documented asthma exacerbations in the last 12 months
  • Exclusion:
    Current smoker
    Former smoker with a smoking history of greater than 10 pack years

    •